ClinicalTrials.gg
Sign In

Drug

AT-511 clinical trials

Also written AT-527 and RO7496998.

studies test it
19
open now
1
in phase 3
1
first study started
2017

Keep track of what changes. Save the AT-511 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

BEM (AT-527)/RZR (AT-038)
3
Bemnifosbuvir
2

Development codes

AT-527
10
RO7496998
3
Portia® 21
1

Combined with it in one product

AT-527 is also know as R07496998
2
AT-527 and Probenecid
1
AT-527 + digoxin
1
Drug: AT-527 + rosuvastatin
1
AT-527 + rosuvastatin
1

Studies by the year they started

19 studies that test it; most in 2021 (9)

Studies that test AT-511, by start year
YearStudies
20171
20191
20202
20219
20222
20231
20253

By phase

A phase 1/2 study counts in both.

Phase 1
15
Phase 2
4
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it.

COVID-19
3
Hepatitis C, Chronic
3

Who runs them

Industry 19 · Other 0

Atea Pharmaceuticals, Inc. (17) · Hoffmann-La Roche (2)

Often tested with

Tested in the same studies.

Bemnifosbuvir (2) · Ruzasvir (1) · Omeprazole (1) · Probenecid (1) · Digoxin (1) · Rosuvastatin (1) · Daclatasvir (1) · AT-777 (1)

Studies

Open first, then newest update. How each study uses AT-511 is read from its arms, and is right about nine times in ten.

Testing it · 19